Hopefully news will start flowing more readily from hereonin. What would be great for the company is a bit more exposure from brokers. Pattersons did one a year ago. The big dumpers this week and last thankfully was not due to impending bad news, but I'm assuming sick of waiting for good news. Fingers crossed new investors start jumping on board. I still think if they do get FDA approval for the Air sonea this may become a possible takeover target for the larger ehealth players out there.
ISN Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held